← Leaderboards
Irfan Ahmed Asangani
University Of Michigan At Ann Arbor
$3,696,849
Attributed
$3,696,849
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $631.6K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,696,849 · 5
By mechanism
R01$2,313,757 · 2
R00$747,000 · 1
R21$406,434 · 1
K99$229,658 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Bruce C. Richardson$11,674,875
- James Alan Shayman$8,158,958
- Yusuke Shiozawa$3,431,923
- Shigeki Iwase$7,177,821
Others in their field
Top investigators on “Genetic Transcription”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$69,905,031
- Bing Ren · Ludwig Institute For Cancer Research$61,600,123
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$54,253,356
- Richard Gibbs · Baylor College Of Medicine$53,550,246
- John A Tainer · Scripps Research Institute$51,251,962
- Deepak Srivastava · J. David Gladstone Institutes$50,027,907
Research focus
Genetic TranscriptionSignal TransductionMediatingClinically RelevantOncogenicPhenotypeGenesGrowthTranscriptional RegulationPlayMalignant Neoplasm Of ProstateChromatinChip-SeqDisease ProgressionProstateProstate Cancer CellTherapeutic TargetMolecularAttenuatedCastration Resistant Prostate CancerTranscriptomeBiological ProcessTranscription FactorPrograms
Grant awards (15)
Towards characterization of Epigenetic targets in Prostate Cancer$371,719
R01 · FY2025 · CA · contact PI
Role of MED1 in the AR-dependent transcription in advanced prostate cancer$353,134
R01 · FY2024 · CA · contact PI
Discovery and characterization of exceptionally specific surface oncoprotein LIPI in Ewing Sarcoma$216,512
R21 · FY2024 · CA · contact PI
Role of MED1 in the AR-dependent transcription in advanced prostate cancer$61,988
R01 · FY2024 · CA · contact PI
Role of MED1 in the AR-dependent transcription in advanced prostate cancer$364,284
R01 · FY2023 · CA · contact PI
Discovery and characterization of exceptionally specific surface oncoprotein LIPI in Ewing Sarcoma$189,922
R21 · FY2023 · CA · contact PI
Role of MED1 in the AR-dependent transcription in advanced prostate cancer$49,000
R01 · FY2023 · CA · contact PI
Role of MED1 in the AR-dependent transcription in advanced prostate cancer$371,719
R01 · FY2022 · CA · contact PI
Role of MED1 in the AR-dependent transcription in advanced prostate cancer$371,338
R01 · FY2021 · CA · contact PI
Role of MED1 in the AR-dependent transcription in advanced prostate cancer$370,575
R01 · FY2020 · CA · contact PI
Characterization of Epigenetic Targets in Prostate Cancer$249,000
R00 · FY2017 · CA · contact PI
Characterization of Epigenetic Targets in Prostate Cancer$249,000
R00 · FY2016 · CA · contact PI
Characterization of Epigenetic Targets in Prostate Cancer$249,000
R00 · FY2015 · CA · contact PI
Characterization of Epigenetic Targets in Prostate Cancer$114,829
K99 · FY2015 · CA · contact PI
Characterization of Epigenetic Targets in Prostate Cancer$114,829
K99 · FY2014 · CA · contact PI